Bridgebio Oncology Therapeutics Inc (BBOT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | |
| Operating Expenses | 145,819 | 80,863 | 0 |
| Operating Income | -145,819 | -80,863 | N/A |
| Other Income | 11,775 | 6,588 | 0 |
| Pre-tax Income | -134,044 | -74,275 | 0 |
| Net Income Continuous | -134,044 | -74,275 | N/A |
| Net Income | $-134,044 | $-74,275 | $N/A |
| EPS Basic Total Ops | -4.30 | -5,756.41 | N/A |
| EPS Basic Continuous Ops | -4.30 | -5,756.41 | N/A |
| EPS Diluted Total Ops | -4.30 | -5,756.41 | N/A |
| EPS Diluted Continuous Ops | -4.30 | -5,756.41 | N/A |
| EBITDA(a) | $-145,209 | $-80,655 | $N/A |